Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
05/2004
05/06/2004US20040087568 Substituted anthranilic amide derivatives and methods of use
05/06/2004US20040087491 Electrophilic ketones for the treatment of herpesvirus infections
05/06/2004US20040087434 Trivalent; oxidation resistance; high activity; forming low and high molecular weight polymers based on ligand structure
05/06/2004US20040086744 Luminance, high purity, low cost, and good thermal stability; as emitters for polymeric light-emitting diodes (PLEDs)
05/06/2004EP1415987A1 Nitrogenous aromatic ring compounds
05/06/2004EP1415659A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response
05/06/2004EP1414830A1 Tumour inhibiting lanthane compounds
05/06/2004EP1414829A2 Tumour inhibiting cerium compounds
05/06/2004EP1414814A1 6-aryl-4-aminopicolinates and their use as herbicides
05/06/2004EP1414810A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds
05/06/2004EP1414802A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase
05/06/2004EP1414801A1 Arylamines for the treatment of conditions associated with gsk-3
05/06/2004EP1414800A1 A novel synthesis for heteroarylamine compounds
05/06/2004EP1414790A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments
05/06/2004EP1414783A1 Method for the production of amines by reductive amination of carbonyl compounds under transfer-hydrogenation conditions
05/06/2004EP1414566A1 Palladium catalysts
05/06/2004EP1414525A2 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide
05/06/2004EP1414450A1 (pyridinyl and pyrimidyl)trienoic acid derivatives as retinoid x receptor modulators
05/06/2004EP1414434A1 Compounds which mimic the chemical and biological properties of discodermolide
05/06/2004EP1414301A1 Pyridylpropynyloxyphenyl derivatives for use as herbicides
05/06/2004EP1326836B1 Process for making 3-amino-2-chloro-4-methylpyridine
05/06/2004EP1233828B1 Chiral catalysts for asymmetric acylation and related transformations
05/06/2004EP1163237B1 Amide derivatives
05/06/2004EP1117645B1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use
05/06/2004EP1000033B1 Heterocyclic derivatives which inhibit factor xa
05/06/2004EP0968182B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/06/2004EP0915825B1 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
05/06/2004EP0840727B1 3-hydroxy-2(1h)-pyridinone chelating agents
05/06/2004EP0813409B1 Treatment of cytokine growth factor caused disorders
05/06/2004CA2503588A1 Phenethanolamine derivative for the treatment of respiratory diseases
05/06/2004CA2503245A1 Alkyne derivatives as tracers for metabotropic glutamate receptor binding
05/06/2004CA2502819A1 Inhibitors of glycogen synthase kinase 3
05/06/2004CA2499844A1 Catalyst systems for ethylene oligomerisation to linear alpha olefins
05/05/2004CN1494576A Novel reactive dyes and use thereof for dyeing substrates containing nucleophilic groups
05/05/2004CN1494530A Heterocyclic diamide invertebrate pest control agents
05/05/2004CN1494527A Or tho-substituted and meta-substituted bis-aryl compounds, method for production thereof, their use as medicament, and pharmaceutical preparations containing there compounds
05/05/2004CN1493561A Preparation of substituted pyridine N-oxide compound
05/05/2004CN1148361C Oxyiminoalkanoic acid derivatives
05/05/2004CN1148356C Benzosulfone derivatives
05/05/2004CN1148355C Pyridazin-3-one derivatives and medicines containing the same
05/05/2004CN1148351C Compound for curing vascular complication, its preparing method and treating use
05/05/2004CN1148346C Hydrazine derivs.
05/04/2004US6730792 β3 adrenergic agonists
05/04/2004US6730786 Process for the preparation of pyrazolopyrimidinones
05/04/2004US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants
05/04/2004US6730705 Alkoximino acetic acid amides
05/04/2004US6730686 Methods for inhibiting oxidative modification of proteins
05/04/2004US6730672 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
04/2004
04/29/2004WO2004035737A2 Heterocyclic selective androgen receptor modulators and methods of use thereof
04/29/2004WO2004035589A1 Heterocyclocarboxamide derivatives
04/29/2004WO2004035561A1 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
04/29/2004WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
04/29/2004WO2004035542A1 Functionalised ionic liquids and method for the production thereof
04/29/2004WO2004035525A1 Inhibitors of histone deacetylase
04/29/2004WO2004035522A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
04/29/2004WO2004035065A1 Hypoglycemic substances containing zinc
04/29/2004WO2004034999A2 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
04/29/2004WO2004019868A3 N-biarylmethyl aminocycloalkanecarboxamide derivatives
04/29/2004WO2004018427A8 O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives
04/29/2004WO2004006354A3 Polymeric charge transport compositions and electronic devices made with such compositions
04/29/2004WO2003099810A3 Radiopharmaceuticals for imaging infection and inflammation
04/29/2004WO2003093242A3 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
04/29/2004WO2003086282A3 Nitric oxide donors, compositions and methods of use
04/29/2004WO2003028459A8 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides
04/29/2004WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
04/29/2004WO2002102787A3 Novel sulfonic acid derivatives
04/29/2004WO2002083842A9 Small molecule inhibitors of secretion of proteins encoded by are-mrnas
04/29/2004WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications
04/29/2004US20040082798 Novel amino dicarboxylic acid derivatives with pharmaceutical properties
04/29/2004US20040082796 Reacting a substituted benzonitrile with a cysteine compound
04/29/2004US20040082793 Methods of ortho alkylation
04/29/2004US20040082780 Vanilloid receptor ligands and their use in treatments
04/29/2004US20040082768 Metal chelates and methods of using them for time-resolved fluorescence
04/29/2004US20040082628 Acylated arylcycloalkylamines and their use as pharmaceuticals
04/29/2004US20040082625 Osteoporosis, bone disorders
04/29/2004US20040082619 Pyridone derivatives having affinity for cannabinoid 2-type receptor
04/29/2004US20040082611 Novel sulfonyl derivatives
04/29/2004US20040082601 Anti-inflammatory compounds
04/29/2004US20040082597 Use of CRF antagonists and related compositions
04/29/2004US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders
04/29/2004US20040082569 Novel substituted amides, their preparation and use
04/29/2004US20040082553 Novel florfenicol-type antibiotics
04/29/2004US20040082497 For treatment of growth hormone deficiency/polycystic ovary syndrome autoimmune/inflammatory disease
04/29/2004US20040082496 For the treatment of body weight disorders (obesity/anorexia/ bulemia/cachexia)
04/29/2004CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
04/29/2004CA2502227A1 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain
04/29/2004CA2501867A1 Heterocyclic selective androgen receptor modulators and methods of use thereof
04/29/2004CA2501265A1 Inhibitors of histone deacetylase
04/29/2004CA2496633A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
04/28/2004EP1412515A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists
04/28/2004EP1412364A1 Platelet adp receptor inhibitors
04/28/2004EP1412343A1 New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias
04/28/2004EP1412331A1 Process for the production of 4-amino-2,5-bisheterocyclylquinazolines
04/28/2004EP1412327A2 Inhibitors of protein kinase for the treatment of disease
04/28/2004EP1412326A1 Butyric acid derivatives
04/28/2004EP1412324A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
04/28/2004EP1411984A2 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug
04/28/2004EP1411965A1 Methods and compositions for controlling protein assembly or aggregation
04/28/2004EP1411945A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists
04/28/2004EP1411941A2 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists